Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock...

Accesswire11/25 20:00

Quantum Biopharma Announces That Sentinel Dosing Has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

Accesswire10/29 19:30

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

Accesswire09/25 21:20

Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis

Accesswire09/09 19:30

Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80

Accesswire08/30 22:30

Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update

Accesswire08/24 07:30